Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: PIK3CA mutations associated with a poor postoperative prognosis in patients with pulmonary pleomorphic carcinoma: a retrospective cohort study

Fig. 1

Summary of four genomic mutations of 55 patients with pulmonary pleomorphic carcinoma. All mutations, including variants of unknown significance (VUSs) in TP53, ATM, PIK3CA and EGFR, were detected in 54 (98%), 5 (9%), 10 (18%) and 21 (38%) patients, respectively. Pathogenic mutations in TP53, ATM, PIK3CA and EGFR were detected in 25 (45%), 0 (0%), 4 (7%) and 5 (9%) patients, respectively

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us